Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times
Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times
Whole blood clotting time measurements are to collect the clotting time ranges for DOAC-anticoagulated patients and assess their correlation with plasma drug levels (via anti-FXa assay).
Primary objectives of the planned whole blood clotting time measurements are to collect the clotting time ranges for DOAC-anticoagulated patients and assess their correlation with plasma drug levels (via anti-FXa assay).
Inclusion Criteria:
In general, study participants must:
Exclusion Criteria:
Eligible patients on anticoagulants must not:
peter.verhamme@uzleuven.be3216343491
s.bakhru@perospheretech.com475 237-4178